NASDAQ:DBVT

DBV Technologies - DBVT News Today

$1.87

-0.18 (-8.78%)

(As of 09/23/2022 12:00 AM ET)

Add

Compare

Today's Range: $1.82
▼
$1.98
50-Day Range: $1.87
▼
$2.76
52-Week Range: $1.15
▼
$5.60

Volume: 113,256 shs
Average Volume: 85,941 shs
Market Capitalization: $351.65 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $5.63

Get DBV Technologies News Delivered to You Automatically

DBVT Media Mentions By Week

DBVT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

DBVT
News Sentiment
▼
0.51

0.38
▲
Average
Medical
News Sentiment

DBVT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

DBVT Articles
This Week
▼
8

1
▲
DBVT Articles
Average Week

Source

Source	Headline
	DBV Technologies S.A. (NASDAQ:DBVT) Given Consensus Recommendation of "Hold" by Brokerages marketbeat.com - September 22 at 4:11 AM
	DBV Technologies S.A.: DBV Technologies Provides Clinical Update on VITESSE Phase 3 Trial finanznachrichten.de - September 23 at 1:06 PM
	FDA Slaps Partial Hold On DBV Technologies' Pivotal Trial Of Peanut Allergy Patch finance.yahoo.com - September 22 at 11:38 AM
	FDA Imposes Partial Hold On DBV Technologies' Phase III VITESSE Study markets.businessinsider.com - September 22 at 11:38 AM
	After-Hours Movers: Salesforce Gains on Strong LT Guidance, KB Home Falls Post... ca.investing.com - September 21 at 7:26 PM
	After-Hours Movers: Salesforce Gains on Strong LT Guidance, KB Home Falls Post EPS investing.com - September 21 at 7:26 PM
	DBV Technologies Provides Clinical Update on VITESSE Phase 3 Trial finance.yahoo.com - September 21 at 7:26 PM
	DBV Technologies Kickstarts Phase 3 Study Of Modified Viaskin Patch For Kids With Peanut Allergy msn.com - September 10 at 8:56 AM
	DBV Technologies Announces Initiation of Phase 3 Study (VITESSE) Using the Modified Viaskin Peanut Patch in Peanut -Allergic Children Ages 4 to 7 Years finance.yahoo.com - September 7 at 8:43 PM
	Aquestive Therapeutics Strengthens Team to Align with Strategic Focus on Allergy Space finance.yahoo.com - August 10 at 5:39 PM
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
	Recap: DBV Technologies Q2 Earnings msn.com - August 1 at 11:02 PM
	DBV Technologies Reports Second Quarter 2022 Financial Results finance.yahoo.com - August 1 at 6:01 PM
	Monthly information regarding the total number of voting rights and total number of shares of the Company as of June 30, 2022 finance.yahoo.com - July 20 at 8:39 PM
	DBV Technologies: Good Data, Plenty Of Cash And Regulatory Uncertainty seekingalpha.com - July 9 at 7:19 AM
	DBV Technologies S.A.: DBV Technologies to Participate in Upcoming EAACI 2022 Congress finanznachrichten.de - June 28 at 7:10 PM
	DBV Technologies to Participate in Upcoming EAACI 2022 Congress finance.yahoo.com - June 28 at 7:10 PM
	DBV Technologies S.A.: DBV Technologies to Present at the JMP Securities Life Sciences Conference in New York finanznachrichten.de - June 17 at 4:32 PM
	Has DBV Technologies (DBVT) Outpaced Other Medical Stocks This Year? finance.yahoo.com - June 9 at 8:38 PM
	DBV Technologies S.A.: DBV Technologies Announces Private Placement Financing of $194 Million finanznachrichten.de - June 9 at 5:33 AM
	DBV Technologies Announces Private Placement Financing of $194 Million tmcnet.com - June 9 at 5:33 AM
	The Daily Biotech Pulse: FDA Adcomm Backing For Novavax's COVID-19 Shot, New Data On Moderna's Omicron Vaccine, DBV Tech's Encouraging Peanut Allergy Trial Data msn.com - June 8 at 5:41 PM
	DBV Technologies Shares Jump On Positive Data From Peanut Allergy Trial In Toddlers finance.yahoo.com - June 8 at 5:41 PM
	DBV Technologies S.A.: DBV Technologies Announces Positive Topline Results from Phase 3 EPITOPE Trial of Viaskin Peanut in Peanut-Allergic Toddlers finanznachrichten.de - June 7 at 5:10 PM
	DBV Technologies Announces Positive Topline Results from Phase 3 EPITOPE Trial of Viaskin Peanut in Peanut-Allergic Toddlers finance.yahoo.com - June 7 at 5:10 PM
	Monthly information regarding the total number of voting rights and total number of shares of the Company as of April 30, 2022 finance.yahoo.com - May 17 at 8:45 PM
	DBV Technologies S.A.: DBV Technologies Announces Results of Its 2022 Ordinary and Extraordinary General Meeting finanznachrichten.de - May 13 at 2:05 AM
	DBV Technologies Announces Results of Its 2022 Ordinary and Extraordinary General Meeting finance.yahoo.com - May 13 at 2:05 AM
	DBV Technologies S.A.: DBV Technologies Completes ADSs Sale of an amount of $15.3 million on Nasdaq through its At-The-Market program (ATM) finanznachrichten.de - May 4 at 11:33 PM
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
	DBV Technologies S.A. (DBVT) CEO Daniel Tassé on Q1 2022 Results - Earnings Call Transcript seekingalpha.com - May 2 at 10:32 PM
	DBV Technologies S.A.: DBV Technologies Establishes an At-The-Market (ATM) Program on Nasdaq finanznachrichten.de - May 2 at 5:32 PM
	DBV Technologies Reports Recent Business Developments and First Quarter 2022 Financial Results finance.yahoo.com - May 2 at 5:32 PM
	DBV Technologies Establishes an At-The-Market (ATM) Program on Nasdaq finance.yahoo.com - May 2 at 5:32 PM
	DBV Technologies S.A.: Correction: DBV Technologies to Report First Quarter 2022 Financial Results and Recent Business Developments finanznachrichten.de - April 26 at 12:38 AM
	Correction: DBV Technologies to Report First Quarter 2022 Financial Results and Recent Business Developments finance.yahoo.com - April 26 at 12:38 AM
	DBV Technologies S.A.: DBV Technologies to Report First Quarter 2022 Financial Results and Recent Business Developments finanznachrichten.de - April 25 at 7:37 PM
	DBV Technologies to Report First Quarter 2022 Financial Results and Recent Business Developments finance.yahoo.com - April 25 at 7:37 PM
	Ordinary and Extraordinary General Meeting of May 12, 2022 finance.yahoo.com - April 21 at 5:49 PM
	Monthly information regarding the total number of voting rights and total number of shares of the Company as of March 31, 2022 finance.yahoo.com - April 14 at 6:21 PM
	DBV Technologies to Present at the Oppenheimer’s 32nd Annual Healthcare Conference finance.yahoo.com - March 14 at 5:31 PM
	Monthly information regarding the total number of voting rights and total number of shares of the Company as of February 28, 2022 finance.yahoo.com - March 11 at 4:35 PM
	DBV Technologies S.A.: DBV Technologies Announces Filing of 2021 Annual Report on Form 10-K and 2021 Universal Registration Document finanznachrichten.de - March 9 at 6:07 PM
	DBV Technologies Announces Filing of 2021 Annual Report on Form 10-K and 2021 Universal Registration Document finance.yahoo.com - March 9 at 6:07 PM
	DBV TECHNOLOGIES earnings preview: what Wall Street is expecting markets.businessinsider.com - March 4 at 1:00 PM
	DBV Technologies stock slumps 21% amid FY revenue decline, plans on Peanut patch seekingalpha.com - March 4 at 1:00 PM
	DBV Technologies S.A.: DBV Technologies Reports Full Year 2021 Financial Results and Recent Business Updates finanznachrichten.de - March 3 at 4:46 PM
	DBV Technologies Reports Full Year 2021 Financial Results and Recent Business Updates finance.yahoo.com - March 3 at 4:46 PM
	DBV Technologies FY 2021 Earnings Preview seekingalpha.com - March 3 at 8:20 AM
	DBV Technologies to Report Full Year 2021 Financial Results and Business Updates on March 3, 2022 finance.yahoo.com - February 24 at 7:11 PM
	DBV Technologies to Participate in Upcoming AAAAI 2022 Congress finance.yahoo.com - February 22 at 4:57 PM
	DBV Technologies S.A.: DBV Technologies to Present at the 11th Annual SVB Leerink Global Healthcare Conference finanznachrichten.de - February 14 at 7:15 PM
	DBV Technologies to Present at the 11th Annual SVB Leerink Global Healthcare Conference finance.yahoo.com - February 14 at 7:15 PM

Get DBV Technologies News Delivered to You Automatically

This page (NASDAQ:DBVT) was last updated on 9/25/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial Subscription Here

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms